Early molecular response to nilotinib in patients who failed imatinib is associated with a higher probability of cytogenetic response in chronic myeloid leukemia (CML)
journal contribution
posted on 2010-06-01, 00:00 authored by T Hughes, D Kim, G Martinelli, S Branford, M Muller, L Beppu, H Goh, S Soverini, Y Shou, John Reynolds, R Woodman, H Kantarjian, G Saglio, J Radich, A HochhausEarly molecular response to nilotinib in patients who failed imatinib is associated with a higher probability of cytogenetic response in chronic myeloid leukemia (CML)
History
Journal
HaematologicaVolume
95Issue
Supp 2Season
Abstract no.: 0135Pagination
54 - 54Publisher
Ferrata Storti FoundationLocation
Pavia, ItalyISSN
0390-6078eISSN
1592-8721Language
engNotes
Poster presentation; Abstract book for European Hematology Association. Congress (15th : 2010 : Barcelona,Spain) held from 10 - 13 Jun. 2010Publication classification
C2.1 Other contribution to refereed journalUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC